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ABSTRACT 
Background/Aims: In the advanced stage of hepatobiliary malignancies, concurrent 
hepatopancreatoduodenectomy (HPD) is necessary to accomplish curative resection, 
even though high rates of morbidity and mortality still remain. Methodology: We 
examined the surgical records and outcome in 11 patients undergoing HPD. Results: In 
11 patients, diseases included bile duct carcinomas in 7 patients, gallbladder carcinomas 
in 3, and ampullar carcinoma in one. Hemi-hepatectomy with resection of the caudate 
lobe was performed in 8 patients and resection of segment 4 and 5 of the liver in two. 
Pancreatoduodenectomy (PD) was performed in 3 patients and pylorus preserving PD in 
8. Curative resection was accomplished in 8 patients. Two patients underwent adjuvant 
photodynamic therapy because of a cancer-positive margin. Morbidity rate was 36% but 
no hospital deaths were reported. The tumor recurrence rate was 73% and 8 patients died 
of cancer. Patient prognosis of gallbladder cancers (12±1 months) tended to be shorter 
than in patients with bile duct cancers (19±11 months) (p=0.15).  Three patients with bile 
duct cancers survived without tumor relapse over 12 months. Conclusions: Complete 
surgical resection (R0) by HPD could be safely performed for diseases of the 
hepatobiliary malignancies, which achieved longer survival in some patients. 
KEYWORDS: hepatectomy, pancreatoduodenectomy, biliary malignancy 
ABBREVIATIONS: Bile duct carcinomas (BDC), gallbladder carcinomas (GBC), 
hepatopancreatoduodenectomy (HPD), pancreatoduodenectomy (PD) 
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INTRODUCTION 
In recent years, surgical resection is the only curable treatment for advanced biliary 
malignancies, and a concurrent hepatopancreatoduodenectomy (HPD) is often necessary 
to accomplish complete (R0) resections (1-4). The resectability of hepatobiliary 
malignancies has markedly improved with the improvement of operative techniques (5, 
6). However, physical stress in patients is severe and postoperative morbidity and 
mortality rate are still not low (7, 8). Therefore, the indication for HPD should be 
carefully decided. In the present report, we examined our results of HPD in patients with 




We analyzed 11 patients with biliary malignancies who underwent surgical resection 
in the Division of Surgical Oncology, Department of Translational Medical Sciences, 
Nagasaki University Graduate School of Biomedical Sciences (NUGSBS) between 1996 
and 2006. The study design was approved by the Human Ethics Review Board of our 
institution.  Informed consent for data collection was obtained by each patient during this 
period. Anesthetic and patient data were retrieved in the NUGSBS database. Tumor stage 
and curability was followed by the Classification of Biliary Tract Carcinoma by the 
Japanese Society of Biliary Surgery (9). 
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Operative indications, procedures and follow-up 
The indication of HPD at our institute was described as follows: 1) malignant biliary 
diseases needing hepatic resection, which extends to duodenum and pancreatic head, 2) 
biliary malignancies with remarkably metastatic lymph node at peri-pancreatic head, 3) 
cases where cancer lesions could be completely (= radically) resected by HPD without 
liver metastasis, peritoneal dissemination, para-aortic lymph node metastasis or more 
distant metastasis, and 4) good general conditions and liver functions but border of 
patient age was not decided.  
In liver resection, the volume to be resected is estimated preoperatively based on the 
results of indocyanine green retention rate at 15 minutes (ICGR15) using Takasaki’s 
formula (10).  The liver volume, excluding tumor volume (cm3), is measured by CT 
volumetry (11).  We routinely clamped the hepatoduodenal ligament to occlude total 
inflow to the liver during transection (Pringle’s maneuver).  We also routinely used the 
forceps fracture method (12) and an ultrasonic dissector (USU MH-207, Olympus, Tokyo, 
Japan) for the transection of liver parenchyma.  In pancreatic resection, 
pancreatoduodenectomy (PD) was usually performed in HPD. Pancreatic functions were 
not considered as operative indications. 
After discharge from hospital, the patient status, laboratory data, and disease 
recurrence were checked every 2 to 3 months.  
 
RESULTS 
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        Patients included 6 men and 5 women with a mean age of 67.3 ± 8.0 years (± SD, 
range, 54-77 years) (Table 1).  Diseases included bile duct carcinomas in 7 patients, 
gallbladder carcinomas in 3, and ampullar carcinoma in 1 patient. Reasons for liver 
resection were direct hepatic invasion of gallbladder carcinoma in 3 patients, extended 
hilar bile duct carcinoma in 7 and superficially wide extension to hilar bile duct of the 
ampullar carcinoma in 1 patient. Reasons for pancreatic resection included lymph node 
metastasis involving pancreatic head of gallbladder carcinoma in 3 patients, superficially 
wide extension of bile duct carcinoma to lower bile duct in the pancreas head in 7 patients, 
and advanced ampullar carcinoma in 1 patient. 
Right hepatectomy with resection of caudate lobe was performed in 5 patients, left 
hepatectomy with resection of caudate lobe in 3, and partial resection of segment 4 and 5 
of the liver in 2 patients. PD was performed in 3 patients and pylorus preserving PD in 8 
patients. All patients underwent loco-regional lymphadenectomy (Table 2). The 
operation time ranged between 494 and 984 minutes (mean was 703 ± 144 minutes) and 
blood loss ranged between 910 and 2920 minutes (mean was 1778 ± 654 mL). Tumor 
stage with stage IV was observed in 8 patients (73%). Curability A and B was 
accomplished in 8 patients and 3 had curability C due to positive cancer margin at hepatic 
cut end, which caused superficial extension of carcinoma along the intra-epithelium. Two 
underwent adjuvant photodynamic therapy after surgery in patients with curability C. 
        Postoperative complications were observed in 4 patients (36%) but no hospital death. 
These complications subsided within a few weeks (Table 3).  Duration of hospital stay 
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ranged between 35 and 76 days (mean was 51±14 days). In 8 patients (73%), tumor 
recurrence was observed and liver metastasis was dominant. These 8 patients died of 
cancer recurrence. Compared between diseases, the survival period in patients with 
gallbladder cancer (12±1 months) tended to be shorter than that in patients with biliary 
malignancies (19±11 months) (p=0.15). Three patients with bile duct cancers survived 
without tumor relapse at 15, 12, and 12 months at this stage. 
 
DISCUSSION 
Nowadays, aggressive surgical exploration for hepatobiliary malignancy combined 
with hepatic resection and pancreatoduodenectomy is performed (1-4). However, the 
usefulness of such an aggressive approach remains controversial because highly 
advanced tumors are dominant in such cases (13). As the techniques and perioperative 
management have improved remarkably, our group has actively performed HPD for 
complete tumor resections (R0) during the last decade. Based on previous reports, the 
usefulness of HPD has been mainly reported by Japanese surgeons since the 1990s (1-4, 7, 
8). This operative procedure is usually performed for bile duct carcinoma and gallbladder 
carcinoma (1-8). In our series, bile duct carcinoma was dominant. One ampullar 
carcinoma extended to the hilar bile duct by skip infiltration, which has not been reported 
previously. Widely intramural extensions of bile duct carcinoma between intra-hepatic 
bile duct and intra-pancreatic bile duct can be completely resected by HPD (8, 14-16), 
which is the best indication of this procedure. Other indications are direct invasion or 
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lymph node metastasis around the pancreatic head of gallbladder carcinoma (8, 15-17).  
In these indications, the usefulness of PD for lymphadenectomy was still limited (18). In 
the advanced stages of gall bladder carcinomas, extended surgical resection might 
provide a survival benefit, based on recent reports (15, 19, 20). In our series, 3 patients 
with gall bladder carcinomas underwent HPD for lymphadenectomy; however, tumor 
recurrence in the liver and lymph node were observed early on.  
In the present series, right hepatectomy with caudate lobe resection was performed 
for bile duct carcinoma in 5 patients. HPD with right hepatectomy might be risky for 
post-operative hepatic failure because of a large volume of resection (21). In such cases, 
preoperative portal vein embolization might prevent such a lethal complication (22, 23). 
By applying this technique, we can safely perform HPD with right hepatectomy at present. 
In the present series, pylorus preserving PD was mainly performed. Pylorus preserving 
PD is physiologically better for post-operative nutrition than the usual Whipple’s 
procedure (24). For the purpose of lymphadenectomy, Whipple’s operation should not be 
necessary in many cases because peri-pancreatic head lymph node dissection is preferred 
over peri-pylorus lymph node dissection in biliary malignancies (25). In 3 patients with 
Whipple’s operation, enlarged lymph nodes were observed at peri-pylorus lesions, and 
metastasis was suspected in 1 case, and ischemia of the duodenum near the pylorus was 
remarkable in 2 cases. Operating time and blood loss gradually improved by 
improvement of surgical techniques in our series. However, HPD is still a high level 
operation in the upper abdomen. HPD was performed to accomplish curative operation; 
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however, 3 patients showed curability C. Unexpected wide extension of intramural 
carcinoma in the intrahepatic bile duct was found in these cases, even after HPD was 
performed. In cases with remnant cancer cells at surgical cut end of the bile duct, 
additional local treatment is necessary to avoid tumor relapse. In 2 patients, 
photodynamic therapy, which is a cancer-specific treatment (26), was performed after the 
operation. As a result, local tumor recurrence has not been observed in these patients. 
      Post-operative complications were observed in 4 patients, but the complications were 
not severe, and there were no hospital stay deaths. Morbidity and mortality rates were 
still high, particularly in cases with combined vascular resections at this stage (4, 8, 15, 
16, 27). Hospital stay was longer than in patients undergoing other abdominal surgeries. 
To tolerate such an aggressive operation, the indication of HPD should be carefully 
considered and selected (8). With respect to long-term prognosis, tumor relapse was 
frequent even after the aggressive resections, particularly in gall bladder carcinomas, in 
the present series. The usefulness of PD for lymphadenectomy in gall bladder 
carcinomas was reported (20); however, locally advanced carcinomas, such as cases 
accompanied with bile duct infiltration, might be avoided because of extremely poor 
prognoses (28). On the other hand, longer prognosis would be expected in bile duct 
carcinomas with wide extension by complete and aggressive resection (16, 29). 
 In conclusion, major surgical resection with simultaneous hepatic resection and 
pancreaticoduodenectomy (HPD) was performed in 11 patients with biliary malignancies 
at a single cancer center over the past10 years. HPD could be safely performed because of 
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low morbidity rate and no mortality at this stage. In patients with bile duct and ampullar 
cancer, long-term survival could be obtained in some cases and, therefore, the indication 
of HPD should be considered for widely extensive bile duct cancer. On the other hand, the 
indication of HPD for patients with gallbladder cancer with peri-pancreatic lymph node 
metastasis should be carefully considered because of early recurrence.  
 
REFERENCES 
1. Hirono S, Tani M, Kawai M, Ina S, Uchiyama K, Yamaue H: Indication of 
hepatopancreatoduodenectomy for biliary tract cancer. World J Surg 
2006;30:567-573 
2. Aiura K, Shimazu M, Takahashi S, Kitajima M: Clinical evaluation of 
hepatopancreatoduodenectomy (in Japanese with English abstract). Nippon Geka 
Gakkai Zasshi. 2001;102:226-231. 
3. Noie T, Seyama Y, Imamura H, Kobayashi A, Miyagawa S, Kawasaki S, 
Makuuchi M: Indication and outcome of extended right hemihepatectomy combined 
with pancreatoduodenectomy for bile duct carcinoma (in Japanese with English 
abstract). Nippon Geka Gakkai Zasshi. 2001;102:215-219. 
4. Nakamura S, Nishiyama R, Yokoi Y, Serizawa A, Nishiwaki Y, Konno H, Baba 
S, Muro H: Hepatopancreatoduodenectomy for advanced gallbladder carcinoma. 
Arch Surg 1994;129:625-629. 
5. Aldrighetti L, Pulitano C, Arru M, Catena M, Finazzi R, Ferla G: 
"Technological" approach versus clamp crushing technique for hepatic parenchymal 
transection: a comparative study. J Gastrointest Surg 2006;10:974-979. 
6. Imaizumi T, Hatori T, Tobita K, Fukuda A, Takasaki K, Makuuchi H: 
Pancreaticojejunostomy using duct-to-mucosa anastomosis without a stenting tube. J 
Hepatobiliary Pancreat Surg 2006;13:194-201. 
7. Takahama T: Post operative complications after hepatopancreatoduodenectomy 
(HPD). (in Japanese with English abstract) Nippon Geka Gakkai Zasshi 
2001;102:220-225. 
Nanashima et al., Page 10 of 12 
8. Hirono S, Tani M, Kawai M, Ina S, Uchiyama K, Yamaue H: Indication of 
hepatopancreatoduodenectomy for biliary tract cancer. World J Surg 
2006;30:567-573. 
9. Japanese Society of Biliary Surgery (JSBS). In: Nagakawa T ed. Classification of 
Biliary Tract Carcinoma. Tokyo: Kanehara & Co., Ltd., 2004, p.11-50. 
10. TakasakiI T, Kobayashi S, Suzuki S, Muto H, Marada M, Yamana Y, 
Nagaoka T: Predetermining postoperative hepatic function for hepatectomies. Int 
Surg 1980; 65:309-313. 
11. Kubota K, Makuuchi M, Kusaka K, Kobayashi T, Miki K, Hasegawa K, 
Harihara Y, Takayama T： Measurement of liver volume and hepatic functional 
reserve as a guide to decision-making in resection surgery for hepatic tumors. 
Hepatology 1997; 26:1176-1181. 
12. Takayama T, Makuuchi M, Kubota K, Harihara Y, Hui AM, Sano K, Ijichi M, 
Hasegawa K: Randomized comparison of ultrasonic vs clamp transection of the liver. 
Arch Surg 2001;136:922-928. 
13. Malhi H, Gores GJ: Cholangiocarcinoma: modern advances in understanding a 
deadly old disease. J Hepatol 2006;45:856-867. 
14. Sakamoto E, Nimura Y, Hayakawa N, Kamiya J, Kondo S, Nagino M, Kanai M, 
Miyachi M, Uesaka K: The pattern of infiltration at the proximal border of hilar bile 
duct carcinoma: a histologic analysis of 62 resected cases. Ann Surg 
1998;227:405-411. 
15. Nagakawa T, Kayahara M: Indication for and problems of 
hepatopancreatoduodenectomy for carcinoma of the biliary tract based on the 
statistical registry in Japan. (in Japanese with English abstract) Nippon Geka Gakkai 
Zasshi 2001;102:199-202. 
16. Yoshimi F, Asato Y, Amemiya R, Shioyama Y, Itabashi M: Comparison between 
pancreatoduodenectomy and hepatopancreatoduodenectomy for bile duct cancer. 
Hepatogastroenterology. 2001;48:994-998. 
17. Principe A, Del Gaudio M, Ercolani G, Golfieri R, Cucchetti A, Pinna AD: 
Radical surgery for gallbladder carcinoma: possibilities of survival. 
Hepatogastroenterology 2006;53:660-664. 
Nanashima et al., Page 11 of 12 
18. Shirai Y, Wakai T, Hatakeyama K: Radical lymph node dissection for gallbladder 
cancer: indications and limitations. Surg Oncol Clin N Am 2007;16:221-232. 
19. Nakamura S, Suzuki S, Konno H, Baba S, Baba S: Outcome of extensive surgery 
for TNM stage IV carcinoma of the gallbladder. Hepatogastroenterology. 
1999;46:2138-2143. 
20. Sasaki R, Takahashi M, Funato O, Nitta H, Murakami M, Kawamura H, Suto T, 
Kanno S, Saito K: Hepatopancreatoduodenectomy with wide lymph node dissection 
for locally advanced carcinoma of the gallbladder--long-term results. 
Hepatogastroenterology 2002;49:912-915. 
21. Nanashima A, Yamaguchi H, Shibasaki S, Ide N, Morino S, Sumida Y, Tsuji T, 
Sawai T, Nakagoe T, Nagayasu T: Comparative analysis of postoperative morbidity 
according to type and extent of hepatectomy. Hepatogastroenterology 
2005;52:844-888. 
22. Kawasaki S, Imamura H, Kobayashi A, Noike T, Miwa S, Miyagawa S: Results 
of surgical resection for patients with hilar bile duct cancer: application of extended 
hepatectomy after biliary drainage and hemihepatic portal vein embolization. Ann 
Surg. 2003;238:84-92. 
23. Nimura Y, Kamiya J, Kondo S, Nagino M, Uesaka K, Oda K, Sano T, 
Yamamoto H, Hayakawa N: Aggressive preoperative management and extended 
surgery for hilar cholangiocarcinoma: Nagoya experience. J Hepatobiliary Pancreat 
Surg 2000;7:155-162. 
24. Niedergethmann M, Shang E, Farag Soliman M, Saar J, Berisha S, Willeke F, 
Post S: Early and enduring nutritional and functional results of pylorus preservation 
vs classic Whipple procedure for pancreatic cancer. Langenbecks Arch Surg 
2006;391:195-202. 
25. Tran KT, Smeenk HG, van Eijck CH, Kazemier G, Hop WC, Greve JW, 
Terpstra OT, Zijlstra JA, Klinkert P, Jeekel H: Pylorus preserving 
pancreaticoduodenectomy versus standard Whipple procedure: a prospective, 
randomized, multicenter analysis of 170 patients with pancreatic and periampullary 
tumors. Ann Surg 2004;240:738-745. 
Nanashima et al., Page 12 of 12 
26. Nanashima A, Yamaguchi H, Shibasaki S, Ide N, Sawai T, Tsuji T, Hidaka S, 
Sumida Y, Nakagoe T, Nagayasu T: Adjuvant photodynamic therapy for bile duct 
carcinoma after surgery: a preliminary study. J Gastroenterol 2004;39:1095-1101. 
27. Miyazaki M, Ito H, Kimura F, Shimizu H: Postoperative complications and 
management in the surgical treatment for advanced gallbladder carcinomas. (in 
Japanese with English abstract) Nippon Geka Gakkai Zasshi 2002;103:564-570. 
28. Kaneoka Y, Yamaguchi A, Isogai M, Harada T, Suzuki M: Hepatoduodenal 
ligament invasion by gallbladder carcinoma: histologic patterns and surgical 
recommendation. World J Surg 2003;27:260-265. 
29. Nakamura S, Suzuki S, Serizawa A, Sakaguchi T, Konno H, Baba S, Muro H: 
Hepatopancreatoduodenectomy for superficially spreading bile duct carcinoma: a 
report of two 5 year survivals. Hepatogastroenterology 1996;43:138-142. 
 
Age Gender Diseases Reasons for hepatectomy
Reasons for
pancreatoduodenectomy
1 54 Male GBC Hepatic invasion Lymph node metastasis
2 69 Male GBC Hepatic invasion Lymph node metastasis
3 73 Male BDC Extension to hilar BD Extension to intra-pancreatic BD
4 67 Male AC Extension to hilar BD AC
5 55 Female BDC Extension to hilar BD Extension to intra-pancreatic BD
6 71 Female BDC Extension to hilar BD Extension to intra-pancreatic BD
7 58 Male BDC Extension to hilar BD Extension to intra-pancreatic BD
8 72 Female GBC Hepatic invasion Lymph node metastasis
9 69 Male BDC Extension to hilar BD Extension to intra-pancreatic BD
10 77 Female BDC Extension to hilar BD Extension to intra-pancreatic BD
11 75 Female BDC Extension to hilar BD Extension to intra-pancreatic BD
Table 1. Patient demographics
GBC; gallbladder cancer, BDC; bile duct cancer, AC; ampullar cancer, BD; bile duct 





1 PD + extended RH 565 2920 IVa B
2 PPPD + resection of segment 4 and 5 615 1892 IVa A
3 PPPD + extended LH 715 910 IVa B
4 PPPD + right lateral sectionectomy 615 2050 IVb C
5 PPPD + extended RH 623 1620 II B
6 PPPD + extended LH 494 2000 III B
7 PPPD + extended RH 695 2500 IVa C
8 PD + resection of segment 4 and 5 730 1000 IVb B
9 PD + extended LH 827 2200 III B
10 PPPD + extended RH 867 950 IVa C
11 PPPD + extended RH 984 1520 IVa B
Table 2. Surgical findings and tumor staging
PD; pancreatoduodenectomy, PPPD; pylorus preserving pancreatoduodenectomy
RH; right hepatectomy, LH; left hepatectomy
* Classification of Biliary Tract Carcinoma by the Japanese Society of Biliary Surgery
Complications Hospital stay (days) Tumor recurrence Prognosis (months)
1 Pancreatic fistula 76 Liver Cancer death (12)
2 None 35 Liver, lymph node Cancer death (13)
3 Pancreatic fistula 47 Liver Cancer death (29)
4 None 33 Liver, lung Cancer death (32)
5 None 41 Liver Cancer death (35)
6 None 41 Local recurrence Cancer death (9)
7 None 58 Peritoneum Cancer death (13)
8 None 47 Liver Cancer death (11)
9 None 56 None Survive (15)
10 Delayed gastric empty 58 None Survive (12)
11 Abscess, Liver failure 69 None Survive (12)
Table 3. Patient outcomes
